ANALYSIS OF THE ROLE OF THE BRCA1 AND BRCA 2 GENES AS A PREDICTOR OF BREAST CANCER. PREVALENCE OF BREAST CANCER IN THE REPUBLIC OF UZBEKISTAN

Authors

  • Nodira I.Tursunova PhD, Associate Professor, Department of Oncology, Tashkent Medical Academy. Tashkent, Uzbekistan
  • Shirina A.Valijonova 5th year student of the medical faculty of the Tashkent Medical Academy. Tashkent, Uzbekistan
  • Azizbek F.Valijonov 5th year student of the medical faculty of the Tashkent Medical Academy. Tashkent, Uzbekistan

Keywords:

Breast cancer, risk factors, BRCA1 and BRCA2

Abstract

According to the World Health Organization, breast cancer is the most common type of cancer, with over 2.2 million cases reported in 2020. One in twelve women will develop breast cancer in their lifetime, which is the leading cause of cancer death in women. In 2020, about 685,000 women died from this disease. In the structure of malignant neoplasms for 2020, the leading position in our Republic is occupied by breast cancer, while the incidence rate is 11.2 per 100,000 population

References

National Breast Cancer Foundation, inc. Genetic Testing for Breast Cancer.

National Breast Cancer Foundation, inc. BRCA: The Breast Cancer Gene.

National Cancer Institute. BRCA Mutations: Cancer Risk and Genetic Testing.

Mayo Clinic. BRCA gene test for breast and ovarian cancer risk.

Jesse T. Casaubon; John-Paul Regan. BRCA 1 and 2. Treasure Island (FL): StatPearls Publishing; 2019 Jan-.

Genetics Home Reference. BRCA1 gene.

Genetics Home Reference. BRCA2 gene.

Ielizaveta Gorodetska, Iryna Kozeretska, and Anna Dubrovska. BRCA Genes: The Role in Genome Stability, Cancer Stemness and Therapy Resistance. J Cancer. 2019; 10(9): 2109–2127. Published online 2019 May 14. doi: 10.7150/jca.30410.

Official site of the RUSSCO program. Mutations in the BRCA1 and BRCA2 genes.

Federal State Budgetary Institution "National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov" of the Ministry of Health of the Russian Federation. Oncogenetics. mutations in the brca1, brca 2 and chek2 genes associated with breast and ovarian cancer.

Xuan Li and Wolf-Dietrich Heyer. Homologous recombination in DNA repair and DNA damage tolerance. Cell Res. author's manuscript; available in PMC 2011 May 4. Cell Res. 2008 Jan; 18(1): 99–113. doi: 10.1038/cr.2008.1.

L.N. Lyubchenko, E.I. Batenev. Medical genetic counseling and DNA diagnostics for hereditary predisposition to breast cancer and ovarian cancer. A guide for doctors. Federal State Budgetary Scientific Institution “Russian Cancer Research Center named after N.N. Blokhin.

Register of medicines of Russia. Tamoxifen.

Inês Godet and Daniele M. Gilkes. BRCA1 and BRCA2 mutations and treatment strategies for breast cancer. Integr Cancer Sci Ther. author's manuscript; available in PMC 2017 Jul 11. doi: 10.15761/ICST.1000228

Downloads

Published

2023-02-17

How to Cite

Nodira I.Tursunova, Shirina A.Valijonova, & Azizbek F.Valijonov. (2023). ANALYSIS OF THE ROLE OF THE BRCA1 AND BRCA 2 GENES AS A PREDICTOR OF BREAST CANCER. PREVALENCE OF BREAST CANCER IN THE REPUBLIC OF UZBEKISTAN. World Bulletin of Public Health, 19, 186-188. Retrieved from https://scholarexpress.net/index.php/wbph/article/view/2199

Issue

Vol. 19 (2023): WBPH

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.